Cardinal Health, Inc. is an American multinational health care services company.
| Revenue (TTM) | $254.25B |
| Gross Profit (TTM) | $9.77B |
| EBITDA | $4.24B |
| Operating Margin | 1.33% |
| Return on Equity | 0.00% |
| Return on Assets | 3.72% |
| Revenue/Share (TTM) | $1077.32 |
| Book Value | $-12.37 |
| Price-to-Book | 16.07 |
| Price-to-Sales (TTM) | 0.22 |
| EV/Revenue | 0.231 |
| EV/EBITDA | 16.88 |
| Quarterly Earnings Growth (YoY) | 68.80% |
| Quarterly Revenue Growth (YoY) | 5.80% |
| Shares Outstanding | $232.58M |
| Float | $231.86M |
| % Insiders | 0.44% |
| % Institutions | 90.88% |
Volatility is currently contracting
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Cardinal (CAH) possesses solid growth attributes, which could help it handily outperform the market.
Cardinal Health delivered FY2026 non-GAAP EPS of $11.26, exceeding initial guidance and achieving over 30% growth, despite a slight revenue miss. CAH's profit mix is shifting toward higher-margin specialty and 'Other' businesses, making traditional distributor revenue metrics less relevant to earnings power. Management guides 13–15% EPS growth for FY2027, with my estimate at $13.10, implying 7–14% upside to a $258–$275 target range.
Cardinal Health targets 13%-15% fiscal 2027 EPS growth as pharma demand normalizes and specialty, At-Home and buybacks remain key priorities for execution.
Cardinal Health beats fiscal Q4 EPS estimates as profit surges, while revenues miss; fiscal 2027 guidance points to continued earnings growth.
Cardinal Health NYSE: CAH reported fourth-quarter fiscal 2026 results marked by growth in revenue, operating earnings and adjusted earnings per share, supported by demand in its pharmaceutical and specialty businesses and a one-time tariff-related benefit in its medical products segment.
Pre-market futures are correcting Monday's slight selloff at this hour; ultimately, as we had said in this space yesterday, we don't expect much movement either direction until inflation reports begin to hit the tape Wednesday morning with the Consumer Price Index (CPI) Inflation Rate. The Dow is +71 points presently, the S&P 500 +16 and the Nasdaq +129 points.
We don't expect much movement either direction until inflation reports begin to hit the tape Wednesday morning.
Although the revenue and EPS for Cardinal (CAH) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Cardinal Health (CAH) came out with quarterly earnings of $2.91 per share, beating the Zacks Consensus Estimate of $2.42 per share. This compares to earnings of $2.08 per share a year ago.
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on CAH and any ticker you trade — then tracks every position and per-strategy win rate.
